LIST OF TABLES

TABLE 01.GLOBAL ANTI-VIRAL THERAPIES MARKET, BY APPLICATION, 2018-2026 ($MILLION)
TABLE 02.HIV ANTI VIRAL THERAPIES MARKET BY REGION, 2018-2026 ($MILLION)
TABLE 03.HEPATITIS ANTI VIRAL THERAPIES MARKET BY REGION, 2018-2026 ($MILLION)
TABLE 04.HERPES VIRUS ANTI VIRAL THERAPIES MARKET BY REGION, 2018-2026 ($MILLION)
TABLE 05.INFLUENZA ANTI VIRAL THERAPIES MARKET BY REGION, 2018-2026 ($MILLION)
TABLE 06.OTHER APPLICATIONS ANTI VIRAL THERAPIES MARKET BY REGION, 2018-2026 ($MILLION)
TABLE 07.GLOBAL ANTI-VIRAL THERAPIES MARKET, BY TYPE, 2018-2026 ($MILLION)
TABLE 08.ANTI-VIRAL THERAPIES MARKET FOR GENERIC DRUGS, BY REGION, 2018-2026 ($MILLION)
TABLE 09.ANTI-VIRAL THERAPIES MARKET FOR BRANDED DRUGS, BY REGION, 2018-2026 ($MILLION)
TABLE 10.GLOBAL ANTI-VIRAL THERAPIES MARKET, BY MECHANISM OF ACTION, 2018-2026 ($MILLION)
TABLE 11.ANTI-VIRAL THERAPIES MARKET, FOR NUCLEOTIDE POLYMERASE INHIBITOR, BY REGION, 2018-2026 ($MILLION)
TABLE 12.ANTI-VIRAL THERAPIES MARKET FOR REVERSE TRANSCRIPTASE INHIBITORS, BY REGION, 2018-2026 ($MILLION)
TABLE 13.ANTI-VIRAL THERAPIES MARKET FOR PROTEASE INHIBITORS, BY REGION, 2018-2026 ($MILLION)
TABLE 14.ANTI-VIRAL THERAPIES MARKET FOR OTHERS, BY REGION, 2018-2026 ($MILLION)
TABLE 15.GLOBAL ANTI-VIRAL THERAPIES MARKET BY REGION, 2018-2026, ($MILLION)
TABLE 16.NORTH AMERICA ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 17.NORTH AMERICA ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 18.NORTH AMERICA ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 19.NORTH AMERICA ANTI-VIRAL THERAPIES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 20.U.S. ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 21.U.S. ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 22.U.S. ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 23.CANADA ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 24.CANADA ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 25.CANADA ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 26.MEXICO ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 27.MEXICO ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 28.MEXICO ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 29.EUROPE ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 30.EUROPE ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 31.EUROPE ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 32.EUROPE ANTI-VIRAL THERAPIES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 33.GERMANY ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 34.GERMANY ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 35.GERMANY ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 36.FRANCE ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 37.FRANCE ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 38.FRANCE ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 39.UK ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 40.UK ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 41.UK ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 42.ITALY ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 43.ITALY ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 44.ITALY ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 45.SPAIN ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 46.SPAIN ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 47.SPAIN ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 48.REST OF EUROPE ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 49.REST OF EUROPE ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 50.REST OF EUROPE ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 51.ASIA-PACIFIC ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 52.ASIA-PACIFIC ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 53.ASIA-PACIFIC ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 54.ASIA-PACIFIC ANTI-VIRAL THERAPIES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 55.JAPAN ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 56.JAPAN ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 57.JAPAN ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 58.CHINA ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 59.CHINA ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 60.CHINA ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 61.INDIA ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 62.INDIA ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 63.INDIA ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 64.AUSTRALIA ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 65.AUSTRALIA ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 66.AUSTRALIA ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 67.SOUTH KOREA ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 68.SOUTH KOREA ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 69.SOUTH KOREA ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 72.REST OF ASIA-PACIFIC ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 73.LAMEA ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 74.LAMEA ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 75.LAMEA ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 76.LAMEA ANTI-VIRAL THERAPIES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 77.BRAZIL ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 78.BRAZIL ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 79.BRAZIL ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 80.SAUDI ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 81.SAUDI ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 82.SAUDI ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 83.SOUTH AFRICA ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 84.SOUTH AFRICA ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 85.SOUTH AFRICA ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 86.REST OF LAMEA ANTI-VIRAL THERAPIES MARKET BY TYPE, 2018-2026, ($MILLION)
TABLE 87.REST OF LAMEA ANTI-VIRAL THERAPIES MARKET BY MECHANISM OF ACTION, 2018-2026, ($MILLION)
TABLE 88.REST OF LAMEA ANTI-VIRAL THERAPIES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 89.ABBOTT: COMPANY SNAPSHOT
TABLE 90.ABBOTT: OPERATING SEGMENTS
TABLE 91.ABBOTT: PRODUCT PORTFOLIO
TABLE 92.ABBVIE: COMPANY SNAPSHOT
TABLE 93.ABBVIE: OPERATING SEGMENTS
TABLE 94.BMS: COMPANY SNAPSHOT
TABLE 95.BMS: OPERATING SEGMENTS
TABLE 96.BMS: PRODUCT PORTFOLIO
TABLE 97.ROCHE: COMPANY SNAPSHOT
TABLE 98.ROCHE: OPERATING SEGMENTS
TABLE 99.ROCHE: PRODUCT PORTFOLIO
TABLE 100.J&J: COMPANY SNAPSHOT
TABLE 101.J&J: OPERATING SEGMENTS
TABLE 102.MERCK: COMPANY SNAPSHOT
TABLE 103.MERCK: OPERATING SEGMENTS
TABLE 104.GILEAD: COMPANY SNAPSHOT
TABLE 105.GILEAD: OPERATING SEGMENTS
TABLE 106.GILEAD: PRODUCT PORTFOLIO
TABLE 107.GSK.: COMPANY SNAPSHOT
TABLE 108.GSK: OPERATING SEGMENTS
TABLE 109.GSK: PRODUCT PORTFOLIO
TABLE 110.ASTRAZENECA: COMPANY SNAPSHOT
TABLE 111.ASTRAZENECA: OPERATING SEGMENTS
TABLE 112.ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 113.AUROBINDO: COMPANY SNAPSHOT
TABLE 114.AUROBINDO: OPERATING SEGMENTS
TABLE 115.AUROBINDO: PRODUCT PORTFOLIO

LIST OF FIGURE

LIST OF FIGURES

FIGURE 01.ANTI-VIRAL THERAPIES MARKET SEGMENTATION
FIGURE 01.TOP INVESTMENT POCKETS
FIGURE 02.TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
FIGURE 03.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019* (%)
FIGURE 04.TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
FIGURE 05.TOP IMPACTING FACTORS
FIGURE 06.COMPARATIVE ANALYSIS OF HIV ANTI VIRAL THERAPIES MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 07.COMPARATIVE ANALYSIS OF HEPATITIS ANTI VIRAL THERAPIES MARKE BY COUNTRY, 2018 & 2026 (%)
FIGURE 08.COMPARATIVE ANALYSIS OF HERPES VIRUS ANTI VIRAL THERAPIES MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 09.COMPARATIVE ANALYSIS OF INFLUENZA ANTI VIRAL THERAPIES MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.COMPARATIVE ANALYSIS OF OTHER APPLICATIONS ANTI VIRAL THERAPIES MARKET BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.ANTI-VIRAL THERAPIES FOR GENERIC DRUGS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.ANTI-VIRAL THERAPIES MARKET FOR BRANDED DRUGS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF ANTI-VIRAL THERAPIES MARKET, FOR NUCLEOTIDE POLYMERASE INHIBITOR BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF ANTI-VIRAL THERAPIES MARKET FOR REVERSE TRANSCRIPTASE INHIBITORS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF ANTI-VIRAL THERAPIES MARKET FOR PROTEASE INHIBITORS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF ANTI-VIRAL THERAPIES MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17.ABBOTT: NET SALES, 2016-2018 ($MILLION)
FIGURE 18.ABBOTT: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 19.ABBOTT: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 20.ABBVIE: NET SALES, 2016-2018 ($MILLION)
FIGURE 21.ABBVIE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 22.ABBVIE: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 23.BMS: NET SALES, 2016-2018 ($MILLION)
FIGURE 24.BMS: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 25.BMS: REVENUE SHARE BY REGION, 2018(%)
FIGURE 26.ROCHE: NET SALES, 2016-2018 ($MILLION)
FIGURE 27.ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 28.ROCHE: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 29.J&J: NET SALES, 2016-2018 ($MILLION)
FIGURE 30.J&J: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 31.J&J: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 32.MERCK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 33.MERCK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 34.GILEAD: REVENUE, 2016-2018($MILLION)
FIGURE 35.GILEAD: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 36.GSK: REVENUE, 2016-2018($MILLION)
FIGURE 37.GSK: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 38.GSK: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 39.ASTRAZENECA: NET SALES, 2016-2018 ($THOUSAND)
FIGURE 40.ASTRAZENECA: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 41.ASTRAZENECA: REVENUE SHARE BY REGION, 2018 (%)
FIGURE 42.AUROBINDO: NET SALES, 2016-2018 ($MILLION)
FIGURE 43.AUROBINDO: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 44.AUROBINDO: REVENUE SHARE BY REGION, 2018 (%)